The antibody is isolated from the serum of COVID-19 vaccine recipient and is recombinantly produced from human 293 cells (HEK293). This antibody can broadly neutralize SARS-CoV-2 Variants of Concerns (VOCs) including Alpha, Beta, Gamma, Del 1 * 100 µG
Catalog # ACRBSPD-M401A100UG
Supplier: ACRO Biosystems
Frequently Bought Together